Gates Foundation Strategic Investment Fund Logo
Share this page:

Enko Raises $70M Series C to Commercialize Safe Crop Protection through Machine-Learning based Discovery Treatment

Congratulations to our portfolio company Enko Chem on their Series C funding round of $70M, led by Nufarm. We look forward to seeing how their machine learning-based discovery pushes forward the industry’s R&D.

Read the full Press Release here



Vir to extend COVID-19 treatment approach to HIV, malaria with $50M from Gates Foundation

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday.

Read the full Press Release  here.

The Bill and Melinda Gates Foundation has invested in OneLoad, a Pakistani tech firm that facilitates small shops through its micro-retailer digitisation and payment platform

The Bill and Melinda Gates Foundation has invested in a Pakistani tech firm that facilitates small shops through its micro-retailer digitisation and payment platform…OneLoad is one of the largest mass market financial access platforms in the country that enable its retailers to deliver telecom, digital payments and banking services to over 7 million unbanked customers each month.


Read the full Press Release here.

Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, and UNICEF Announce $150 Million Guarantee to Support Access to Vaccines and Health Supplies in Low- and Middle-Income Countries

SEATTLE – STOCKHOLM – COPENHAGEN (November 12, 2021) – The Bill & Melinda Gates Foundation, the Swedish International Development Cooperation Agency (Sida), and UNICEF today announced a $150 million financial guarantee to help UNICEF procure vaccines and other health-related supplies for low- and middle-income countries (LMICs).


Read the full Press Release here.

Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot

[November 10, 2021] Inventprise has been slowly growing in Redmond, Wash., expanding into four research and manufacturing facilities to support early development of a host of vaccines since its founding in 2012.

The company is now set to advance an investigational vaccine for pediatric pneumococcal disease into human testing with new funding from the Bill & Melinda Gates Foundation.


Read the full Press Release here.

Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

[September 8, 2021] Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, today announced a four-year collaboration with the Bill & Melinda Gates Foundation, a non-profit focused on fighting global poverty, disease, and inequity, to develop small molecule therapeutics that tackle the current Coronavirus pandemic and help prepare for future pandemics.


Read the full Press Release here.

Avanti Finance raises $26mm from Oikocredit, Nomura, Gates Foundation

Bengaluru, [7th April, 2021]: Bengaluru based Avanti Finance (“Avanti”), a technology led NBFC focused  on financial inclusion, has raised US$26 million (INR 195 crores) in debt and equity from Oikocredit,  Nomura and the Bill & Melinda Gates Foundation. Technopreneur cum philanthropist Pratul Shroff &  existing investor NRJN Trust also participated in the round. Avanti will use the funds to strengthen its  platform and expand its presence to accelerate livelihoods purpose credit and other financial products to  the next 100 million unserved and underserved households in India.

Read the full Press Release here.

Adjuvant Capital Announces $300 Million Venture Fund Designed to Improve Global Public Health

NEW YORKFeb. 18, 2021 /PRNewswire/ – Adjuvant Capital announced an oversubscribed $300 million fund focused on accelerating the development of medical innovations for historically overlooked public health challenges.

Read the full press release here.

Investing for Impact: A Q&A with Vidya Vasu-Devan

Last month, Vidya Vasu-Devan became the new director of the foundation’s Strategic Investment Fund (SIF). We spoke with her about the role of SIF at the foundation and her plans for the fund’s future.

Read the full article here.

Provivi raises $10m from Gates Foundation to bring insect pheromone tech to smallholder farmers

The fall armyworm is considered by many to be the most destructive and costly pest that farmers battle around the globe, especially for smallholder farmers. With limited access to inputs or a lack of financial means to purchase the right products, controlling the fall armyworm is often a losing battle. Novel pest management startup Provivi is teaming up with the Bill & Melinda Gates Foundation to make the fight a little fairer for smallholder farmers in developing countries.

Read the full article here.